Answers are grounded in this paper and cite their sources.
Repeated administration of gadodiamide lead to a retention of gadolinium preferentially within DCN at 1 year postinjections. This retention did not lead to any detectable changes of the measured metabolic biomarkers nor histological alterations.
No takes yet. Share an insight, caveat, or question.
Hamrani et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: